Literature DB >> 16610058

Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

Fabio Farinati1, Romilda Cardin, Marina Bortolami, Maria Guido, Massimo Rugge.   

Abstract

AIM: To assess whether a correlation exists between oxidative DNA damage occurring in chronic HCV-related hepatitis and expression levels of pro-inflammatory cytokines, TGF-alpha and c-myc.
METHODS: The series included 37 patients with chronic active HCV-related hepatitis and 11 with HCV-related compensated cirrhosis. Eight-hydroxydeoxyguanosine in liver biopsies was quantified using an electrochemical detector. The mRNA expression of TNF-alpha, IL-1beta, TGF-alpha and c-myc in liver specimens was detected by semi-quantitative comparative RT-PCR.
RESULTS: TNF-alpha levels were significantly higher in hepatitis patients than in cirrhosis patients (P=0.05). IL-1beta was higher in cirrhosis patients (P=0.05). A significant correlation was found between TNF-alpha and staging (P=0.05) and between IL-1beta levels and grading (P=0.04). c-myc showed a significantly higher expression in cirrhosis patients (P=0.001). Eight-hydroxydeoxyguanosine levels were significantly higher in cirrhosis patients (P=0.05) and in HCV genotype 1 (P=0.03). Considering all patients, 8-hydroxydeoxyguanosine levels were found to be correlated with genotype (P=0.04) and grading (P=0.007). Also multiple logistic regression analysis demonstrated a significant correlation among the number of DNA adducts, TNF-alpha expression and HCV genotype (P=0.02).
CONCLUSION: In chronic HCV-related liver damage, oxidative DNA damage correlates with HCV genotype, grading and TNF-alpha levels. As HCV-related liver damage progresses, TNF-alpha levels drop while IL-1beta and c-myc levels increase, which may be relevant to liver carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610058      PMCID: PMC4087686          DOI: 10.3748/wjg.v12.i13.2065

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Oxidative DNA damage in cancer patients: a cause or a consequence of the disease development?

Authors:  Ryszard Olinski; Daniel Gackowski; Rafal Rozalski; Marek Foksinski; Karol Bialkowski
Journal:  Mutat Res       Date:  2003-10-29       Impact factor: 2.433

Review 2.  Biochemical aspects of free radicals.

Authors:  H S Basaga
Journal:  Biochem Cell Biol       Date:  1990 Jul-Aug       Impact factor: 3.626

Review 3.  The role of 8-hydroxyguanine in carcinogenesis.

Authors:  R A Floyd
Journal:  Carcinogenesis       Date:  1990-09       Impact factor: 4.944

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine.

Authors:  C G Fraga; M K Shigenaga; J W Park; P Degan; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.

Authors:  Masahide Ikeguchi; Yasuaki Hirooka
Journal:  Pathobiology       Date:  2004       Impact factor: 4.342

7.  TNF-alpha induced DNA damage in primary murine hepatocytes.

Authors:  Nicholas M Wheelhouse; Yuen-Sum Chan; Sheona E Gillies; Helen Caldwell; James A Ross; David J Harrison; Sandrine Prost
Journal:  Int J Mol Med       Date:  2003-12       Impact factor: 4.101

8.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

9.  Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues.

Authors:  Y Kuchino; F Mori; H Kasai; H Inoue; S Iwai; K Miura; E Ohtsuka; S Nishimura
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

10.  Oxidative damage to DNA: relation to species metabolic rate and life span.

Authors:  R Adelman; R L Saul; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more
  14 in total

1.  Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis.

Authors:  Satheesh K Sainathan; Kumar S Bishnupuri; Konrad Aden; Qizhi Luo; Courtney W Houchen; Shrikant Anant; Brian K Dieckgraefe
Journal:  Inflamm Bowel Dis       Date:  2011-09-26       Impact factor: 5.325

2.  Cellular immune response to infection by different genotypes of hepatitis C virus.

Authors:  Mohamed El-Shahat Ebeid; Kadry Abdel-Kader El-Bakry
Journal:  Indian J Clin Biochem       Date:  2009-09-16

3.  HCV-related proteins activate Kupffer cells isolated from human liver tissues.

Authors:  Naohiro Hosomura; Hiroshi Kono; Masato Tsuchiya; Kenichi Ishii; Masahito Ogiku; Masanori Matsuda; Hideki Fujii
Journal:  Dig Dis Sci       Date:  2010-09-17       Impact factor: 3.199

4.  Circulating free DNA in the progression of liver damage to hepatocellular carcinoma.

Authors:  Marika Piciocchi; Romilda Cardin; Alessandro Vitale; Veronica Vanin; Anna Giacomin; Caterina Pozzan; Gemma Maddalo; Umberto Cillo; Maria Guido; Fabio Farinati
Journal:  Hepatol Int       Date:  2013-11-02       Impact factor: 6.047

5.  Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.

Authors:  Eduardo Vilar Gomez; Yadina Martinez Perez; Hector Vega Sanchez; Gretel Riveron Forment; Enrique Arus Soler; Luis Calzadilla Bertot; Ali Yasells Garcia; Maria del Rosario Abreu Vazquez; Licet Gonzalez Fabian
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

Review 6.  HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis.

Authors:  Rabia Nawaz; Sadia Zahid; Muhammad Idrees; Shazia Rafique; Muhammad Shahid; Ammara Ahad; Iram Amin; Iqra Almas; Samia Afzal
Journal:  Inflamm Res       Date:  2017-03-11       Impact factor: 4.575

7.  Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress.

Authors:  Howard E Boudreau; Suzanne U Emerson; Agnieszka Korzeniowska; Meghan A Jendrysik; Thomas L Leto
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

Review 8.  Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?

Authors:  Ijaz-S Jamall; Shafaq Yusuf; Maimoona Azhar; Selene Jamall
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 9.  Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway.

Authors:  Romilda Cardin; Marika Piciocchi; Marina Bortolami; Andromachi Kotsafti; Luisa Barzon; Enrico Lavezzo; Alessandro Sinigaglia; Kryssia Isabel Rodriguez-Castro; Massimo Rugge; Fabio Farinati
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.

Authors:  Amy Thomas; Carl Laxton; Joanne Rodman; Nisha Myangar; Nigel Horscroft; Tanya Parkinson
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.